Apollon Wealth Management’s Insmed INSM Stock Holding History

Apollon Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,050	Closed	-$295K	–	1344
2025 Q3	$295K	Buy	+2,050	New	+$251K	0.01%	1057

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Apollon Wealth Management's INSM Position: Q4 2025 in Review

Apollon Wealth Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 2,050 shares — an estimated $295K sold.

Apollon Wealth Management first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $295K in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

Apollon Wealth Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
Apollon Wealth Management sold 2,050 Insmed shares in Q4 2025, an estimated $295K.
Apollon Wealth Management first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
Apollon Wealth Management's Insmed position peaked at $295K in Q3 2025.
677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Apollon Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.